Home » Topics » BioWorld Science

BioWorld Science
RSS

BBP-671 restores brain glutamate/glutamine levels in preclinical model of coenzyme A deficiency

March 3, 2022

Immunotherapies targeting WT137-45 may avoid acute myeloid leukemia immune evasion

March 3, 2022

Eoetvoes Lorand Tudomanyegyetem, Semmelweis University patent imipridone derivatives

March 3, 2022

Roche divulges new TLR7/8/9 antagonists

March 3, 2022

Ruhr University Bochum presents new compounds for treating axonal damage

March 3, 2022

New SLC10A2/SLC10A1 inhibitors identified at Albireo

March 3, 2022

Sitryx Therapeutics describes nuclear factor erythroid 2-related factor 2 activators

March 3, 2022

RUNX1 targeting shows promise for treating aggressive PDAC

March 3, 2022

Researchers present CX-10759 anti-IgE antibody for hypersensitivity

March 3, 2022

Targeting PD-1/PD-L1 pathway prevents allergic immune response

March 2, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...